Chief Scientific Officer
CRF
Newton, Massachusetts, United States
Jeffrey Popma is the Chief Scientific and Strategic Officer at CRF. Dr. Popma is also a Program Director for New York Valves and TCT. Until Novemer 2024, Dr. Popma was the Chief Medical Office at Medtronic for Structural Heart, Coronary, and Renal Denervation. . Until June 2020, Dr. Popma was the Director, Interventional Cardiology at the Beth Israel Deaconess Medical Center and Director of the BIDMC Imaging Core Laboratory. Dr. Popma is Professor of Medicine, Emeiritus, Harvard Medical School.
Disclosure(s): Medtronic: CMO ended Nov 2024 (Terminated, November 1, 2024), Stock-publicly held company (excluding mutual/index funds) (Terminated, November 1, 2024)
Multivalular Disease Management Suggestions for Trial Design
Sunday, March 8, 2026
2:24 PM - 2:32 PM EST
Panel Discussion | TAVR Lifetime Management How to Study 3.0 THV
Sunday, March 8, 2026
2:32 PM - 3:15 PM EST
Monday, March 9, 2026
9:50 AM - 10:10 AM EST
Panel Discussion | Mechanical Circulatory Support for High-Risk PCI and Shock
Tuesday, March 10, 2026
8:20 AM - 8:50 AM EST
Tuesday, March 10, 2026
12:30 PM - 1:30 PM EST
Tuesday, March 10, 2026
12:45 PM - 1:00 PM EST
Tuesday, March 10, 2026
1:10 PM - 1:30 PM EST